Differential induction of rat hepatic microsomal and peroxisomal long-chain and nafenopin-CoA ligases by clofibric acid and di-(2-ethylhexyl)phthalate

References

• Aarsland A., Berge R. K. Peroxisome proliferating sulphur- and oxy-substituted fatty acid analogues are activated to acyl coenzyme A thioesters. Biochemical Pharmacology 1991; 41: 53–61
   PubMed Web of Science ®Google Scholar
• Ahmed R. S., Price S. C., Grasso P., Hinton R. H. Effects of intermittent feeding of rats with di-2-ethylhexylphthalate. Biochemical Society Transactions 1989; 17: 1073–1074
   PubMedGoogle Scholar
• Amigo L., McElroy M. C., Morales M. N., Bronfman M. Subcellular distribution and characteristics of ciprofibroy-CoA synthetase in rat liver. Its possible identity with long-chain acyl-CoA synthetase. Biochemical Journal 1992; 284: 283–287
   PubMedGoogle Scholar
• Barry M., Feely J. Enzyme induction and inhibition. Pharmacology and Therapeutics 1990; 48: 71–94
   PubMed Web of Science ®Google Scholar
• Bartlett K., Hovik R., Eaton S., Watmough N. J., Osmundsen H. Intermediates of peroxisomal β-oxidation: a study of the fatty acyl-CoA esters which accumulate during peroxisomal β-oxidation of [U-14C] hexadecanoate. Biochemical Journal 1990; 270: 175–180
   PubMedGoogle Scholar
• Boie Y., Adam M., Rushmore T. H., Kennedy B. P. Enantioselective activation of the peroxisome proliferator-activated receptor. Journal of Biological Chemistry 1993; 268: 5530–5534
   PubMedGoogle Scholar
• Bronfman M., Amigo L., Morales M. N. Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters. Biochemical Journal 1986; 239: 781–784
   PubMed Web of Science ®Google Scholar
• Bronfman M., Morales M. N., Amigo L., Orellana A., Nunez L., Cardenas L., Hidalgo P. C. Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets. Biochemical Journal 1992; 284: 289–295
   PubMed Web of Science ®Google Scholar
• Bronfman M., Orellana A., Morales M. N., Bieri F., Waechter F., Staubli W., Bentley P. Potentiation of diacylglycerol-activated protein kinase C by acyl-coenzyme A thioesters of hypolipidaemic drugs. Biochemical and Biophysical Research Communications 1989; 159: 1026–1031
   PubMed Web of Science ®Google Scholar
• Ganning A. E., Brunk U., Dallner G. Effects of dietary di(2-ethylhexyl)phthalate on the structure and function of rat hepatocytes. Biochimica et Biophysica Acta 1983; 763: 72–82
   PubMedGoogle Scholar
• Gebel T., Arand M., Oesch F. Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver. FEBS Letters 1992; 309: 37–40
   PubMedGoogle Scholar
• Gill J. L. Design and Analysis of Experiments in Animal and Medical Sciences. Iowa State University Press. 1981
   Google Scholar
• Gray T. J., Beamand J. A., Lake B. G., Foster J. R., Gangolli S. D. Peroxisome proliferation in cultured rat hepatocytes produced by clofibrate and phthalate ester metabolites. Toxicology Letters 1982; 10: 273–279
   PubMed Web of Science ®Google Scholar
• Green S. Receptor-mediated mechanisms of peroxisome proliferators. Biochemical Pharmacology 1992; 43: 393–401
   PubMed Web of Science ®Google Scholar
• Gottlicher M., Demoz A., Svensson D., Tollet P., Berge R. K., Gustafsson J. Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochemical Pharmacology 1993; 46: 2177–2184
   PubMed Web of Science ®Google Scholar
• Hawkins J. M., Jones W. E., Bonner F. W., Gibson G. G. The effect of peroxisome proliferators on microsomal, peroxisomal and mitochondrial enzyme activities in the liver and kidney. Drug Metabolism Reviews 1987; 18: 441–515
   PubMed Web of Science ®Google Scholar
• Hayball P. J., Meffin P. J. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. III. Fenoprofen disposition. Journal of Pharmacology Experimental Therapeutics 1987; 240: 631–636
   PubMed Web of Science ®Google Scholar
• Horie S., Isobe M., Suga T. Changes in CoA pools in hepatic peroxisomes of the rat under various conditions. Journal of Biochemistry 1986; 99: 1345–1352
   PubMedGoogle Scholar
• Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645–650
   PubMed Web of Science ®Google Scholar
• Kawashima Y., Hirose A., Kozuka H. Modification by clofibric acid of acyl composition of glycerolipids in rat liver. Possible involvement of fatty acid chain elongation and desaturation. Biochimica et Biophysica Acta 1984; 795: 543–551
   PubMedGoogle Scholar
• Knights K. M., Roberts B. J. Xenobiotic acyl-CoA formation: evidence of kinetically distinct hepatic microsomal long-chain fatty acid and nafenopin-CoA ligases. Chemico Biological Interactions 1994; 90: 215–233
   PubMedGoogle Scholar
• Krisans S. K., Mortensen R., Lazarow P. B. Acyl-CoA synthetase in rat liver peroxisomes. Journal of Biological Chemistry 1980; 255: 9599–9607
   PubMed Web of Science ®Google Scholar
• Lageweg W., Wanders R. J. A., Tager J. M. Long-chain-acyl-CoAa synthetase and very-long-chain-acyl-CoA synthetase activities in peroxisomes and microsomes from rat liver. European Journal of Biochemistry 1991; 196: 519–523
   PubMedGoogle Scholar
• Lalwani N. D., Alvares K., Reddy M. K., Reddy M. N., Parikh I., Reddy J. K. Peroxisome proliferator-binding protein: Identification and partial characterization of nafenopin-,clofibric acid-, and ciprofibrate-binding proteins from rat liver. Proceedings of the National Academy of the Sciences, USA 1987; 84: 5242–5246
   PubMed Web of Science ®Google Scholar
• Lazo O., Contreras M., Singh I. Effect of ciprofibrate on the activation and oxidation of very long chain fatty acids. Molecular and Cellular Biochemistry 1991; 100: 159–167
   PubMedGoogle Scholar
• Lock E. A., Mitchell A. M., Elcombe C. R. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annual Reviews of Pharmacology and Toxicology 1989; 29: 145–163
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Marsman D. S., Cattley R. C., Conway J. G., Popp J. A. Relationship of hepatic peroxisome proliferation and replicative DNS synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chlcro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Research 1988; 48: 6739–6744
   PubMed Web of Science ®Google Scholar
• Milton M. N., Elcombe C. R., Gibson G. G. On the mechanism of induction of microsomal cytochrome P450IVA1 and peroxisome proliferation in rat liver by clofibrate. Biochemical Pharmacology 1990; 40: 2727–2732
   PubMed Web of Science ®Google Scholar
• Miyazawa S., Hashimoto T., Yokota S. Identity of long chain acyl coenzyme A synthetase of microsomes, mitochondria and peroxisomes in rat liver. Journal of Biochemistry 1985; 98: 723–733
   PubMedGoogle Scholar
• Moody D. E., Reddy J. K. The effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes. American Journal of Pathology 1978; 90: 435–445
   PubMed Web of Science ®Google Scholar
• Okey A. B., Roberts E. A., Harper P. A., Denison M. S. Induction of drug-metabolizing enzymes: mechanisms and consequences. Clinical Biochemistry 1986; 19: 132–141
   PubMed Web of Science ®Google Scholar
• Orellana A., Hidalgo P. C., Morales M. N., Mezzano D., Bronfman M. Palmitoyl-CoA and the acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate potentiate diacylglycerol-activated protein kinase C by decreasing the phosphatidylserine requirement of the enzyme. European Journal of Biochemistry 1990; 190: 57–61
   PubMedGoogle Scholar
• Osumi T., Hashimoto T. Enhancement of fatty acyl-CoA oxidising activity in rat liver peroxisomes by di-(2-ethylhexyl)phthalate. Journal of Biochemistry 1978; 83: 1361–1365
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Azarnoff D. L., Hignite C. E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 1980; 283: 397–398
   PubMed Web of Science ®Google Scholar
• Roberts B. J., Knights K. M. Inhibition of rat peroxisomal palmitoyl-CoA ligase by xenobiotic carboxylic acids. Biochemical Pharmacology 1992; 44: 261–267
   PubMed Web of Science ®Google Scholar
• Roberts B. J., MacLeod J. K., Singh I., Knights K. M. Kinetic characteristics of rat liver peroxisomal nafenopin-CoA ligase. Biochemical Pharmacology 1995, in press
   Google Scholar
• Schoonjans K., Staels B., Grimaldi P., Auwerx J. Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation. European Journal of Biochemistry 1993; 216: 615–622
   PubMedGoogle Scholar
• Yoshida Y., Singh I. Effect of Clofibrate on peroxisomal lignoceroyl-CoA ligase activity. Biochemical Medical and Metabolic Biology 1990; 43: 22–29
   PubMedGoogle Scholar